Unknown

Dataset Information

0

Survival benefit of early infant antiretroviral therapy is compromised when diagnosis is delayed.


ABSTRACT: Late presentation is common among African HIV-1-infected infants. Incidence and correlates of mortality were examined in 99 infants with HIV-1 diagnosis by 5 months of age. Twelve-month survival was 66.8% (95% confidence interval: 55.9-75.6%). World Health Organization stage 3 or 4, underweight, wasting, microcephaly, low hemoglobin, pneumonia and gastroenteritis predicted mortality. Early HIV-1 diagnosis with antiretroviral therapy before symptomatic disease is critical for infant survival.

SUBMITTER: Wamalwa D 

PROVIDER: S-EPMC3756892 | biostudies-literature | 2012 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Survival benefit of early infant antiretroviral therapy is compromised when diagnosis is delayed.

Wamalwa Dalton D   Benki-Nugent Sarah S   Langat Agnes A   Tapia Ken K   Ngugi Evelyn E   Slyker Jennifer A JA   Richardson Barbra A BA   John-Stewart Grace C GC  

The Pediatric infectious disease journal 20120701 7


Late presentation is common among African HIV-1-infected infants. Incidence and correlates of mortality were examined in 99 infants with HIV-1 diagnosis by 5 months of age. Twelve-month survival was 66.8% (95% confidence interval: 55.9-75.6%). World Health Organization stage 3 or 4, underweight, wasting, microcephaly, low hemoglobin, pneumonia and gastroenteritis predicted mortality. Early HIV-1 diagnosis with antiretroviral therapy before symptomatic disease is critical for infant survival. ...[more]

Similar Datasets

| S-EPMC4773149 | biostudies-literature
| S-EPMC5844834 | biostudies-literature
| S-EPMC2854555 | biostudies-literature
| S-EPMC3954590 | biostudies-literature
| S-EPMC3457866 | biostudies-other
| S-EPMC9321101 | biostudies-literature
| S-EPMC4143892 | biostudies-literature
| S-EPMC6561661 | biostudies-literature
| S-EPMC5512309 | biostudies-literature
| S-EPMC8023306 | biostudies-literature